Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced ovarian cancer. A Southwest Oncology Group Study

D. D. Von Hoff, R. Kronmal, R. V. O'Toole, E. A. Surwit, J. J. Hutton, D. S. Alberts

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint Dive into the research topics of 'Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced ovarian cancer. A Southwest Oncology Group Study'. Together they form a unique fingerprint.

Medicine & Life Sciences